Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Pulmonology | Surgery | Journal

Back to Journal Articles

Portable Device Feasible for Donor Lung Preservation

Last Updated: October 10, 2012.

 

Pilot study shows lungs are safely preserved; all 12 grafts and patients survived to 30 days

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Donor lungs can be safely preserved and successfully transplanted with the Organ Care System Lung device, according to a pilot study published online Oct. 10 in The Lancet.

WEDNESDAY, Oct. 10 (HealthDay News) -- Donor lungs can be safely preserved and successfully transplanted with the Organ Care System (OCS) Lung device, according to a pilot study published online Oct. 10 in The Lancet.

Gregor Warnecke, M.D., from the Hanover Medical School in Germany, and colleagues report the first-in-man experience of the portable OCS for concomitant preservation, assessment, and transport of donor lungs (from eight female and four males) into seven female and five male recipients. Lungs were perfused with low-potassium dextran solution and explanted. They were then connected immediately to the OCS Lung device and perfused with Steen's solution which was supplemented with two red-cell concentrates.

The researchers found that the ratio of partial pressure of oxygen (PaO2) to fractional concentration of oxygen in inspired air (FIO2) was 463.9 in preharvest donors. Measured with the OCS Lung, the final ratio of PaO2 to FIO2 was 471.58. There was no significant difference between these ratios. At 30 days, all grafts and patients survived and all recipients recovered and were discharged from hospital.

"Lungs can be safely preserved with the OCS Lung, resulting in complete organ use and successful transplantation in our series of high-risk recipients," the authors write. "In November 2011, we began recruitment for a prospective, randomized, multicenter trial (INSPIRE) to compare preservation with OCS Lung with standard cold storage."

The study was funded in part by TransMedics, the manufacturer of the OCS Lung.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Review Compares Effectiveness of Tocolytic Agents Next: Cannabis Relieves Muscle Stiffness in Multiple Sclerosis

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.